Pharmacokinetics of granisetron in rat blood and brain by microdialysis.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Life Science

• Publication date

  1999-04-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0024-3205(99)00143-5PMID 10353590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microdialysis in pharmacokinetics

  2011cited by this paper
• Intravenous Microdialysis in the Mouse and the Rat: Development and Pharmacokinetic Application of a New Probe

  2004cited by this paper
• CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport

  1998cited by this paper
• Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier.

  1997cited by this paper
• The Design and Validation of a Novel Intravenous Microdialysis Probe: Application to Fluconazole Pharmacokinetics in the Freely-Moving Rat Model

  1997cited by this paper
• In vivo microdialysis determination of collagen-induced serotonin release in rat blood.

  1996cited by this paper
• Simultaneous brain and blood microdialysis study with a new removable venous probe. Serotonin and 5-hydroxyindolacetic acid changes after D-norfenfluramine or fluoxetine.

  1996cited by this paper
• Microdialysis Assessment of Microfibrous Collagen Containing a P-Glycoprotein-Mediated Transport Inhibitor, Cyclosporine A, for Local Delivery of Etoposide

  1996cited by this paper
• Measurement and Analysis of Unbound Drug Concentrations

  1996cited by this paper
• Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.

  1995cited by this paper
• Measurement and pharmacokinetic analysis of imipramine and its metabolite by brain microdialysis

  1994cited by this paper
• Characterisation of the cytochrome P450 enzymes involved in the in vitro metabolism of granisetron.

  1994cited by this paper
• SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.

  1993cited by this paper
• In vivo calibration of microdialysis probes for exogenous compounds.

  1992cited by this paper
• 5-HT3 Receptor Antagonists

  1991cited by this paper
• Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting.

  1990cited by this paper
• 5‐HT3 Receptors

  1990cited by this paper
• Effects of Different Semipermeable Membranes on In Vitro and In Vivo Performance of Microdialysis Probes

  1990cited by this paper
• Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.

  1989cited by this paper
• Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).

  1989cited by this paper
• 5‐HT3 receptor antagonists injected into the area postrema inhibit cisplatin‐induced emesis in the ferret

  1989cited by this paper
• In Vivo Microdialysis as a Technique to Monitor Drug Transport: Correlation of Extracellular Cocaine Levels and Dopamine Overflow in the Rat Brain

  1988cited by this paper
• Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis.

  1987cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre.

  1982cited by this paper

• Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat.

  2020cites this paper
• Alterations of colonic sensitivity and gastric dysmotility after acute cisplatin and granisetron

  2018cites this paper
• Review of analytical methodologies for the determination of 5-HT3 receptor antagonists

  2017cites this paper
• Induction and antagonism of pica induced by teriparatide in rats.

  2015cites this paper
• Involvement of substance P in the development of cisplatin‐induced acute and delayed pica in rats

  2014cites this paper
• The Antiemetic 5-HT3 Receptor Antagonist Palonosetron Inhibits Substance P-Mediated Responses In Vitro and In Vivo

  2010cites this paper
• Rapid determination of granisetron in human plasma by liquid chromatography coupled to tandem mass spectrometry and its application to bioequivalence study.

  2006cites this paper
• Dermal, Subdermal, and Systemic Concentrations of Granisetron by Iontophoretic Delivery

  2005cites this paper
• Concurrent determination of thalidomide in rat blood, brain and bile using multiple microdialysis coupled to liquid chromatography.

  2005cites this paper
• Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors.

  2003cites this paper
• Assaying protein unbound drugs using microdialysis techniques.

  2003cites this paper
• The effects of the cyclosporin A, a P‐glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study

  2002cites this paper
• Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography.

  2002cites this paper
• Measurement and pharmacokinetic analysis of unbound cephaloridine in rat blood by on-line microdialysis and microbore liquid chromatography.

  2001cites this paper
• Simultaneous measurement of cefuroxime in rat blood and brain by microdialysis and microbore liquid chromatography. Application to pharmacokinetics.

  1999cites this paper